Form 4: Topsoe Reports Acquisition of IGM Biosciences Stock Through Restricted Stock Units

Christina Teng Topsoe, a director of IGM Biosciences, reports acquiring shares through vested restricted stock units and indirect holdings.

Summary

• Christina Teng Topsoe, a director of IGM Biosciences, filed a Form 4 detailing changes in beneficial ownership.
• On June 28, 2024, Topsoe acquired 2,687 shares of IGM Biosciences common stock through fully vested restricted stock units (RSUs) at a price of $0.
• These RSUs represent a contingent right to receive one share of the Issuer's common stock.
• Vested RSUs will be delivered to the Reporting Person on the earlier of (i) immediately prior to a change in control of the Issuer or (ii) following the Reporting Person's retirement or separation from service with the Issuer.
• Topsoe also has indirect ownership of 10,400,564 shares held by Topsoe Holding A/S and 9,800 shares held by Pillarcater LLC.
• Following the reported transaction, Topsoe directly owns 46,293 shares of IGM Biosciences common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock transactions by a director. The acquisition of shares could be seen as a positive signal, but it's not a major event.

Positives

• Acquisition of shares by a director can be seen as a positive signal, indicating confidence in the company's future.

Future Outlook

The vested RSUs will be delivered to the Reporting Person on the earlier of (i) immediately prior to a change in control of the Issuer or (ii) following the Reporting Person's retirement or separation from service with the Issuer.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. They are closely watched by investors for signals about management's view of the company's prospects.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment.

Key Dates